Context: The evaluation of plasma Viral Load constitutes an indicator of the progression of the infection, the effectiveness and the tolerance of the treatment. Objective: The objective of this study is to present the virological profile of Patients Living with HIV (PLHIV) after 12 months of AntiRetro Viral Treatment (ART) based on Dolutegravir (DTG) in Kinshasa. Method: The present study is a cross-sectional view of the virological profile of the twelfth month of a prospective cohort of PLHIV at M12 of DTG-based ART in Kinshasa. During the M12 appointment, a blood sample was taken for Molecular Biology analyses from all PLHIV included. Result: During the M12 appointment, 28 patients were registered, including 16 (57.1%) women. Nine (9) patients (45.0%) had an undetectable Viral Load (VL). The median VL value was 3.18 log10 RNA copies/mL (1530 RNA copies/mL). The mutations K65R, T69P/N, K70R and M184V have been listed as mutations conferring resistance to Nucleotide Reverse Transcriptase Inhibitors. No mutations associated with Dolutegravir were observed at M12. Conclusion: After 12 months of AntiRetroViral Treatment based on Dolutegravir, half of the Patients on first-line ART are in a state of virological failure.
References
[1]
Girum, T., Yasin, F., Wasie, A., Shumbej, T., Bekele, F. and Zeleke, B. (2020) The Effect of “Universal Test and Treat” Program on HIV Treatment Outcomes and Patient Survival among a Cohort of Adults Taking Antiretroviral Treatment (ART) in Low Income Settings of Gurage Zone, South Ethiopia. AIDS Research and Therapy, 17, Article No. 19. https://doi.org/10.1186/s12981-020-00274-3
[2]
Bongenia, I.B., Ilombo, L.L., Botomwito, T.H., Bulanda, I.B., Kamangu, N.E., Lusakibanza, L.M. and Mesia, K.G. (2014) Suivi des Paramètres Biologiques des patients sous antirétroviraux à l’Hôpital Provincial Général de Référence de Kinshasa de 2006 à 2012. Journal des Recherches BioMédicales, 1, 7-11.
[3]
Kamangu, N.E., Chatté, A., Boreux, R., Kalala, L.R., Mvumbi, L.G., De Mol, P., Vaira, D. and Hayette, M.P. (2014) Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa. Open Access Library Journal, 1, e855. https://doi.org/10.4236/oalib.1100855
[4]
Bongenya, B.I., Tshinguta, C.L., Sombo, M.T.A.S., Bumoko, G.M.M., Kabengele, B.O., Mesia, G.K. and Kamangu, E.N. (2023) Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based AntiRetroViral Treatment in Kinshasa, Democratic Republic of Congo. World Journal of AIDS, 13, 83-94. https://doi.org/10.4236/wja.2023.133008
[5]
Bongenya, B.I., Tshinguta, C.L., Sombo, M.T.A.S., Bumoko, G.M.M., Kabengele, B.O., Mesia, G.K. and Kamangu, E.N. (2023) Virological and Molecular Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa. Under-Press.
[6]
Kamangu, N.E., Nyima, K.V., Kingombe, A.M., Nkutshi, T.W. and Mesia, K.G. (2013) Suivi des patients VIH positifs traités par la Médecine Traditionnelle à Kinshasa: étude rétrospective des dossiers des patients suivis au Centre BONKOKO. Revue Congolaise des Sciences, 1, 50-59.
[7]
Bulanda, B.I., Kateba, E.T., Bongenia, B.I., Kasongo, V.N., Kingombe, M.A. and Kamangu, E.N. (2018) Sociodemographic and Anthropometric Profile of Positive HIV Patients in Early Traditional Treatment: Case of the Bonkoko Center. Open Access Library Journal, 5, e4555. https://doi.org/10.4236/oalib.1104555
[8]
Losenga, L.O., Dikati, N.M., Bongenya, B.I., Ntumba, T.K., Booto, G.I., Dembo, R.D., Selenge, S.M., Nonga, J.E., Kabamba, C.A., Sombo, M.-T.A.S., Bumoko, G.M.M. and Kamangu, E.N. (2022) Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo. Open Access Library Journal, 9, e9056. https://doi.org/10.4236/oalib.1109056
[9]
Bongenya, B.I., Dikati, N.M., Losenga, L.O., Selenge, S.M., Booto, G.I., Ntumba, T.K., Kabengele, B.O., Sombo, M.-T.A.S., Bumoko, G.M.M. and Kamangu, E.N. (2023) Loss of People Living with HIV/AIDS in the Care Centers of Kinshasa, Democratic Republic of the Congo. Open Access Library Journal, 10, e9729. https://doi.org/10.4236/oalib.1109729
[10]
Desclaux, A. and Desgrees du lou, A. (2006) Les femmes africaines à l’épidémie du SIDA. Population et sociétés, 428, 1-4. https://doi.org/10.3917/popsoc.428.0001
[11]
Karier, R. and Marissa, Y. (2009) Renforcement de integration des services de planification familiale et de traitement du VIH. PRB USAID 2009.
[12]
Bongenya, B.I., Kabengele, B.O., Sombo, M.T.A.S., Bumoko, G.M.M., Situakibanza, H.N.T., Kodondi, F.K.K., Mesia, G.K., Lusakibanza, M.M., Kayembe, J.M.N., Mvumbi, G.L., Buassa, B.B., Kalala, R.L. and Kamangu, E.N. (2023) Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo. World Journal of AIDS, 13, 95-115. https://doi.org/10.4236/wja.2023.133009
[13]
Booto, G.I., Selenge, S.M., Bongenya, B.I., Ntumba, T.K., Losenga, L.O., Dikati, N.M., Dembo, R.D., Nonga, J.E., Kabamba, C.A., Kabengele, B.O., Sombo, M.-T.A.S., Bumoko, G.M.M. and Kamangu, E.N. (2022,) Clinical Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of Congo. Open Access Library Journal, 9, e9134. https://doi.org/10.4236/oalib.1109134
[14]
Bongenya, B.I., Sombo, M.T.A.S., Bumoko, G.M.M., Kabengele, B.O., Lusakibanza, M.M., Mesia, G.K. and Kamangu, E.N. (2023) Compliance with First-Line AntiRetroViral Treatment (ART) for HIV Infection in the Era of Dolutegravir in Kinshasa, Democratic Republic of the Congo. World Journal of AIDS, 13, 11-17. https://doi.org/10.4236/wja.2023.131002
[15]
Programme des Nations Unies de Lutte contre le VIH/SIDA (ONUSIDA) (2012) Rapport mondial: rapport de l’ONUSIDA sur l’épidémie mondiale de sida 2012.
[16]
Wensing, A.M., Calvez, V., Ceccherini-Silberstein, F., Charpentier, C., Günthard, H.F., Paredes, R., Shafer, R.W. and Richman, D.D. (2019) 2019 Update of the Drug Resistance Mutations in HIV-1. Topics in Antiviral Medicine, 27, 111.
[17]
Kamangu, N.E., Wumba, D.M.R., Situakibanza, N.T.S., Lukusa, T.P., Kapend, K.L., Mvumbi, L.G., Hayette, M.P. and Kalala, L.R. (2018) Molecular Epidemiology of Human Immunodeficiency Virus Type 1 and Therapeutic Monitoring of Patients treated in Kinshasa/Democratic Republic of the Congo. International Journal of HIV and Aids Research, 2, 6-11.
